Business Wire

CA-AMAZON-PRIME-VIDEO

7.5.2020 20:01:06 CEST | Business Wire | Press release

Share
Amazon Original Series Regular Heroes to Premiere May 8 Highlighting Courageous Stories From the Front-Lines of COVID-19

Regular Heroes is an eight-episode docuseries highlighting the contributions and personal sacrifices of just some of today’s most generous individuals who are going above and beyond to support their communities during the COVID-19 crisis. The series premieres on Amazon Prime Video in the U.S., U.K., Canada and Australia on Friday, May 8. In addition to shining the spotlight on the heroes’ tireless work and amplifying their efforts in cities including New York City, Los Angeles, New Orleans, Chicago, and Seattle among others, the series will offer support and assistance with donations of goods, services and more so that they can continue to pay it forward and help their communities. New episodes of Regular Heroes will be available every Friday. The series will premiere in all other Amazon Prime Video territories May 12, 2020.

In the premiere episode of Regular Heroes, Native New Yorker and 15-time Grammy Award-winning singer, producer and author Alicia Keys will help shine a light on Trevor Henry, Burnell Cotlon and Athena Hayley as they each make personal sacrifices for their families and communities. Additionally, Keys’ moving new song, “Good Job,” will be featured in the series. Subsequent episodes with additional talent and heroes will be announced at a later date.

“This show is Amazzziinngg!!! So pure and genuine! I’m happy to know this series will not only give support to but also put a face on the incredible people like Trevor, Burnell and Hayley. They are the ones we clap for each night at 7pm in New York. These are the Heroes. And I’m so honored to celebrate them!!” said Keys.

“We are so proud to celebrate people who are doing so much to transform the lives of people in their communities. This show is inspired by the individuals who give so much to others every day of the year but even more so during this challenging time. They are true role models and we can’t wait to share their stories with Prime Video customers everywhere,” said Jennifer Salke, Head of Amazon Studios.

Episode One (May 8, 2020): “A New Type Of Hero” with a special appearance by Alicia Keys. Featuring:

TREVOR HENRY (NEW YORK CITY)
Trevor Henry, born and raised in the Bronx, is a husband and father of four who works as a Senior Inventory Specialist at HSS (Hospital for Special Surgery). He spends his 10-hour days supporting doctors and nurses as they tend to the sickest COVID-19 patients in the unit. When Trevor isn’t at the hospital, he’s helping his children with their schoolwork as he swaps shifts with his wife who also is an essential worker at a different hospital in New York.

BURNELL COTLON (NEW ORLEANS)
For the last 10 years, Burnell Cotlon has been a staple in New Orleans’ Lower 9th Ward. After Hurricane Katrina wiped out all viable businesses in the town, Burnell invested his life savings into building a grocery store – “Burnell’s 9th Ward Grocery.” As the only grocery store within a 5-mile radius, Burnell continues to service his customers who have been struck with massive layoffs, including donating food to those in need. His life mission is to get the Lower 9th Ward back on par with the rest of New Orleans.

ATHENA HAYLEY (LOS ANGELES)
After overcoming homelessness, Athena Hayley, who goes by her last name, set out on a mission to help others who found themselves in a similar situation. Never one to give up, once she was off the streets, Hayley rented out the living room of her apartment, just so she could make ends meet and put aside some money to start the “Love My Neighbor Foundation.” For the last five years, Hayley has served as a family figure to the residents at the infamous Skid Row, and through her organization, she helps feed and clothe those in need.

Regular Heroes will feature people making a difference in their cities and communities from all walks of life: Health care and emergency workers, grocery store employees, farmers, bus drivers, delivery personnel, sanitation workers, police officers, and others. If you or someone you know is making an extraordinary difference in their community please visit Regular-Heroes.com to apply.

Regular Heroes is produced by Amazon Studios in association with Philymack, TyTy & Jay Brown Productions and MGM’s Big Fish Entertainment. Philip McIntyre, John Lloyd Taylor, Laurence “Jay” Brown, Tyran “Ty Ty” Smith, Dan Cesareo, Lucilla D’Agostino and Jordana Starr serve as Executive Producers.

About Prime Video

Prime Video offers customers a vast collection of digital videos—all available to watch on practically any device.

  • Included with Prime Video: Watch tons of popular movies and TV shows, award-winning Amazon Originals and other exclusives, sports, and more. Think Emmy Award winners Fleabag and The Marvelous Mrs. Maisel, Tom Clancy’s Jack Ryan, Mindy Kaling’s Late Night , Donald Glover’s Guava Island , Academy Award-nominated The Big Sick, Troop Zero, The Boys, Homecoming , Thursday Night Football and licensed and self-published content. Prime Video is available in more than 240 countries and territories worldwide (offers and titles vary based on location).
  • Prime Video Channels : Prime members can add channels like HBO, Cinemax, STARZ, SHOWTIME, CBS All Access, NBA League Pass and MLB.tv —no extra apps to download, and no cable required. Only pay for the ones you want, and cancel anytime. View the full list of channels available at amazon.com/channels .
  • Rent or Buy : Enjoy new-release movies to rent or buy, entire seasons of current TV shows available to buy, with special deals just for Prime members.
  • Instant access : Watch at home or on the go with your choice of hundreds of compatible devices. Stream from the web or using the Prime Video app on your smartphone, tablet, set-top box, game console, or select smart tv. For a complete list of compatible devices, visit amazon.com/howtostream .
  • Enhanced experiences : Make the most of every viewing with 4K Ultra HD- and High Dynamic Range (HDR)-compatible content. Go behind the scenes of your favorite movies and TV shows with exclusive X-Ray access, powered by IMDb. Save it for later with select mobile downloads for offline viewing.

Prime Video is just one of many benefits included with a Prime membership, along with fast free shipping on millions of items at Amazon.com, unlimited photo storage, exclusive deals and discounts, and access to ad-free music and Kindle ebooks. To sign-up or start a free trial of Amazon Prime visit: amazon.com/prime .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye